Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $627.38 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $314.51 | 17 | $0 (2023) |
| Intercept Pharmaceuticals, Inc. | $73.02 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $70.96 | 4 | $0 (2023) |
| BOSTON SCIENTIFIC CORPORATION | $57.18 | 1 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $32.37 | 1 | $0 (2017) |
| Cook Medical LLC | $25.78 | 2 | $0 (2018) |
| Janssen Biotech, Inc. | $22.01 | 1 | $0 (2023) |
| PFIZER INC. | $18.63 | 1 | $0 (2018) |
| Wilson Cook Medical Incorporated | $12.92 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $151.09 | 7 | ABBVIE INC. ($84.25) |
| 2022 | $82.00 | 4 | ABBVIE INC. ($82.00) |
| 2021 | $54.48 | 3 | AbbVie Inc. ($54.48) |
| 2019 | $109.38 | 3 | Intercept Pharmaceuticals, Inc. ($73.02) |
| 2018 | $136.52 | 6 | BOSTON SCIENTIFIC CORPORATION ($57.18) |
| 2017 | $93.91 | 6 | AbbVie, Inc. ($48.62) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Gastroenterology | ||||||
| 08/28/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/14/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/09/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/07/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Immunology | ||||||
| 04/27/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/21/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Gastroenterology | ||||||
| 11/10/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/02/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/07/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/17/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/19/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/08/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/27/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/12/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/06/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Endocrinology | ||||||
| 06/05/2019 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $73.02 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 12/11/2018 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/10/2018 | Cook Medical LLC | COOK MEDICAL HEMOSPRAY (Device) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: Endoscopy | ||||||
| 06/26/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Immunology | ||||||
| 05/24/2018 | Cook Medical LLC | COOK MEDICAL HEMOSTASIS (Device) | Food and Beverage | Cash or cash equivalent | $12.64 | General |
| Category: Endoscopy | ||||||
| 05/18/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR ORAL (Drug), XIFAXANIBSD | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/26/2018 | BOSTON SCIENTIFIC CORPORATION | EXPECT (Device) | Food and Beverage | In-kind items and services | $57.18 | General |
| Category: BILIARY DEVICES | ||||||
| 11/28/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Immunology | ||||||
| 11/21/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 105 | 106 | $39,495 | $9,521 |
| 2022 | 6 | 192 | 195 | $71,341 | $20,257 |
| 2021 | 6 | 264 | 271 | $94,921 | $25,306 |
| 2020 | 11 | 432 | 477 | $138,673 | $42,159 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 33 | 33 | $18,348 | $6,520 | 35.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 32 | 32 | $14,976 | $1,571 | 10.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 22 | 22 | $5,962 | $1,350 | 22.6% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2023 | 18 | 19 | $209.00 | $79.54 | 38.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 63 | 64 | $35,584 | $12,219 | 34.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 41 | 41 | $19,188 | $2,660 | 13.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 29 | 30 | $8,130 | $2,182 | 26.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2022 | 13 | 13 | $4,472 | $2,094 | 46.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 15 | 15 | $3,615 | $977.12 | 27.0% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2022 | 31 | 32 | $352.00 | $124.81 | 35.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Office | 2021 | 87 | 87 | $48,372 | $16,270 | 33.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 45 | 46 | $12,466 | $3,043 | 24.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 33 | $3,711 | $2,203 | 59.4% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 55 | 55 | $25,740 | $2,185 | 8.5% |
| 43248 | Insertion of guide wire with dilation of esophagus using an endoscope | Office | 2021 | 12 | 13 | $4,225 | $1,449 | 34.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2021 | 37 | 37 | $407.00 | $156.51 | 38.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Office | 2020 | 97 | 98 | $54,488 | $19,181 | 35.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 79 | 87 | $23,304 | $5,990 | 25.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 52 | 71 | $8,380 | $3,530 | 42.1% |
| 43248 | Insertion of guide wire with dilation of esophagus using an endoscope | Office | 2020 | 28 | 30 | $9,950 | $3,130 | 31.5% |
| 45380 | Biopsy of large bowel using an endoscope | Office | 2020 | 51 | 51 | $23,868 | $2,930 | 12.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2020 | 12 | 14 | $4,816 | $2,209 | 45.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 12 | $4,308 | $1,922 | 44.6% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 14 | 16 | $3,808 | $1,229 | 32.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 21 | $3,192 | $1,200 | 37.6% |
About Dr. David Hay, MD
Dr. David Hay, MD is a Gastroenterology healthcare provider based in Waterville, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093804882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hay, MD has received a total of $627.38 in payments from pharmaceutical and medical device companies, with $151.09 received in 2023. These payments were reported across 29 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($627.38).
As a Medicare-enrolled provider, Hay has provided services to 993 Medicare beneficiaries, totaling 1,049 services with total Medicare billing of $97,242. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Waterville, ME
- Active Since 10/12/2006
- Last Updated 11/16/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1093804882
Products in Payments
- LINZESS (Drug) $115.42
- VIBERZI (Drug) $84.25
- OCALIVA (Drug) $73.02
- Humira (Biological) $69.20
- EXPECT (Device) $57.18
- XIFAXAN (Drug) $56.61
- UCERIS TABLETS (Drug) $32.37
- Creon (Drug) $24.58
- STELARA (Biological) $22.01
- CREON (Drug) $21.06
- XELJANZ (Drug) $18.63
- RELISTOR ORAL (Drug) $14.35
- COOK MEDICAL HEMOSPRAY (Device) $13.14
- Cook Medical Biopsy - Non-Biliary (Device) $12.92
- COOK MEDICAL HEMOSTASIS (Device) $12.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Waterville
Sakdhisapol Katanyutanon, M.d, M.D
Gastroenterology — Payments: $1,918
Dr. Gabriel Melki, Md, MD
Gastroenterology — Payments: $657.44
Michael Saletta, Md, MD
Gastroenterology — Payments: $88.43
Dr. Michael Griffin, Md, MD
Gastroenterology